- Sun Life’s Q2 2026 earnings call transcript detailed results with CEO Kevin Strain, CFO Tim Deacon, plus business heads for U.S., Asia, Canada, SLC. - Underlying net income was **USD 1.12 billion**, underlying EPS was **USD 2.02**; reported net income was **USD 1.01 billion**; LICAT ratio was **145%**. - U.S. stop-loss sales rose **86%**; management described Q2 morbidity pressure as expected IBNR seasonality; loss ratios stayed in the mid-70s. - Dental repositioning continued; Medicaid membership fell **9%** on exits of unprofitable contracts; mix shift to commercial is expected over **1-2 years**. - Asia sales rose **20%** to **USD 875 million**; Hong Kong MCV represented about **30%** of sales; new business CSM fell on competition-driven mix.
SLF•SLF•SLF•SLF•
